Panome Bio
Saint Louis, US · Founded 2022 · Delaware corporation · 26 employees on LinkedIn · 3 known investors
Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types. It serves life science and biotechnology researchers looking to identify biomarkers and generate research insights.
Founders & leadership
Panome Bio was founded in 2022 by Edward Weinstein and Tom Cohen.
Board
DS

DL

AH

RC

Investors · 3
Reported raises · per SEC filings
Form D private placements$12M disclosed across 2 rounds · 2023–2024
▶$6MraisedNov 2024 · 6 investors · BiotechnologyRule 506(b)
▶$6MraisedNov 2024 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SmollerDirector
- Tom CohenExecutive Officer
- Rob CaponeDirector
- Edward WeinsteinExecutive Officer, Director
- Deval LashkariDirector
- Offering amount
- $6M
- Amount sold
- $6M
- Minimum investment
- $25K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$6MraisedFeb 2023 · 6 investors · BiotechnologyRule 506(b)
▶$6MraisedFeb 2023 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SmollerDirector
- Deval LashkariDirector
- Alexander HerzickDirector
- Edward WeinsteinExecutive Officer, Director
- Tom CohenExecutive Officer
- Rob CaponeDirector
- Offering amount
- $6M
- Amount sold
- $6M
- Minimum investment
- $20K
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapOup36 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Metabolon27 shared keywordsMetabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data. It serves biopharma, public health, consumer wellness, agriculture, and academic research clients across discovery, clinical, and translational studies.
Companies competing with Panome Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Panome Bio do?
- Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types. It serves life science and biotechnology researchers looking to identify biomarkers and generate research insights.
- Who founded Panome Bio?
- Panome Bio was founded by Edward Weinstein, Tom Cohen in 2022.
- Who are Panome Bio's investors?
- Panome Bio's investors include BioGenerator Ventures, Telegraph Hill Partners, Cultivation Capital.
- How much funding has Panome Bio raised?
- Panome Bio has disclosed $12M raised across 2 rounds.
- Where is Panome Bio headquartered?
- Panome Bio is headquartered in Saint Louis, US.



